Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Midnolin is a confirmed genetic risk factor for Parkinson's disease.
Obara Y, Sato H, Nakayama T, Kato T, Ishii K. Obara Y, et al. Among authors: nakayama t. Ann Clin Transl Neurol. 2019 Nov;6(11):2205-2211. doi: 10.1002/acn3.50914. Epub 2019 Oct 6. Ann Clin Transl Neurol. 2019. PMID: 31588691 Free PMC article.
Reply to: MIDN locus structural variants and Parkinson's disease risk.
Obara Y, Sato H, Nakayama T, Kato T, Ishii K. Obara Y, et al. Among authors: nakayama t. Ann Clin Transl Neurol. 2020 Apr;7(4):604-605. doi: 10.1002/acn3.51011. Epub 2020 Mar 22. Ann Clin Transl Neurol. 2020. PMID: 32200577 Free PMC article. No abstract available.
Re-consideration of Lymph Node Metastasis in Pancreatic Cancer Patients Following Radical Resection: A Retrospective Study.
Saito R, Kawaida H, Izumo W, Nakata Y, Amemiya H, Ozawa T, Higuchi Y, Nakayama T, Maruyama S, Takiguchi K, Shoda K, Ashizawa N, Nakayama Y, Shiraishi K, Furuya S, Akaike H, Kawaguchi Y, Ichikawa D. Saito R, et al. Among authors: nakayama t. Anticancer Res. 2024 May;44(5):2141-2149. doi: 10.21873/anticanres.17020. Anticancer Res. 2024. PMID: 38677773
Combining hemodialysis with peritoneal dialysis improves cognitive function: a three-case report.
Maruki T, Nakayama T, Morimoto K, Uchiyama K, Washida N, Mitsuno R, Tonomura S, Hama EY, Kusahana E, Yoshimoto N, Hishikawa A, Hagiwara A, Azegami T, Yoshino J, Monkawa T, Yoshida T, Yamaguchi S, Hayashi K. Maruki T, et al. Among authors: nakayama t. CEN Case Rep. 2024 Apr 26. doi: 10.1007/s13730-024-00880-4. Online ahead of print. CEN Case Rep. 2024. PMID: 38668925
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients.
Aoki A, Iwamura C, Kiuchi M, Tsuji K, Sasaki A, Hishiya T, Hirasawa R, Kokubo K, Kuriyama S, Onodera A, Shimada T, Nagaoka T, Ishikawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Nakamura S, Urushibara T, Kaneda S, Sakao S, Nishida O, Takahashi K, Kimura MY, Motohashi S, Igari H, Ikehara Y, Nakajima H, Suzuki T, Hanaoka H, Nakada TA, Kikuchi T, Nakayama T, Yokote K, Hirahara K. Aoki A, et al. Among authors: nakayama t. J Clin Immunol. 2024 Apr 22;44(4):104. doi: 10.1007/s10875-024-01708-7. J Clin Immunol. 2024. PMID: 38647550 Free PMC article.
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study.
Yoshinami T, Nagai SE, Hattori M, Okamura T, Watanabe K, Nakayama T, Masuda H, Tsuneizumi M, Takabatake D, Harao M, Yoshino H, Mori N, Yasojima H, Oshiro C, Iwase M, Yamaguchi M, Sangai T, Kosaka N, Tajima K, Masuda N. Yoshinami T, et al. Among authors: nakayama t. Breast Cancer. 2024 Apr 20. doi: 10.1007/s12282-024-01575-5. Online ahead of print. Breast Cancer. 2024. PMID: 38642245
5,188 results